Tags

Type your tag names separated by a space and hit enter

Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar.
N Engl J Med. 2022 02 24; 386(8):799-800.NEJM

Links

PMC Free PDF

Authors+Show Affiliations

Abu-Raddad LJ
Weill Cornell Medicine-Qatar, Doha, Qatar lja2002@qatar-med.cornell.edu.
Chemaitelly H
Weill Cornell Medicine-Qatar, Doha, Qatar lja2002@qatar-med.cornell.edu.
Bertollini R
Ministry of Public Health, Doha, Qatar.
National Study Group for COVID-19 Vaccination
No affiliation info available

MeSH

2019-nCoV Vaccine mRNA-1273BNT162 VaccineCOVID-19COVID-19 VaccinesHumansImmunization, SecondaryQatarRetrospective StudiesVaccine Efficacy

Pub Type(s)

Letter
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

35045222

Citation

Abu-Raddad, Laith J., et al. "Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar." The New England Journal of Medicine, vol. 386, no. 8, 2022, pp. 799-800.
Abu-Raddad LJ, Chemaitelly H, Bertollini R, et al. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. N Engl J Med. 2022;386(8):799-800.
Abu-Raddad, L. J., Chemaitelly, H., & Bertollini, R. (2022). Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. The New England Journal of Medicine, 386(8), 799-800. https://doi.org/10.1056/NEJMc2117933
Abu-Raddad LJ, et al. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. N Engl J Med. 2022 02 24;386(8):799-800. PubMed PMID: 35045222.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. AU - Abu-Raddad,Laith J, AU - Chemaitelly,Hiam, AU - Bertollini,Roberto, AU - ,, Y1 - 2022/01/19/ PY - 2022/1/20/pubmed PY - 2022/3/3/medline PY - 2022/1/19/entrez SP - 799 EP - 800 JF - The New England journal of medicine JO - N Engl J Med VL - 386 IS - 8 SN - 1533-4406 UR - https://www.unboundmedicine.com/medline/citation/35045222/Effectiveness_of_mRNA_1273_and_BNT162b2_Vaccines_in_Qatar_ DB - PRIME DP - Unbound Medicine ER -